ABOLOGIX is admitted to Fondation Eclosion, the Geneva life sciences incubator

Geneva, Switzerland, September 5, 2018

Abologix has been selected to enter Fondation Eclosion, the Geneva Life Sciences incubator supported by the Republique et canton de Genève. Under the program Abologix will receive invaluable business, scientific and financial support.

“We are honoured and grateful to have been selected to participate in this incubation program. This will allow the company to access critical resources required for its growth. We hope to make a lasting contribution to the growth of the biotechnology ecosystem in the city of Geneva”.

said Ignacio Faus, co-founder and Chairman of the Board of Abologix.

Winners in Stage III of the Venture Kick competition

Geneva, Switzerland, May 26, 2021. Abologix has been named one of the winners of the Venture Kick stage III start up competition. “We are extremely happy to have been selected by Venture Kick to recei

Winners in Stage II of the Venture Kick competition

Geneva, Switzerland, November 1, 2020. Abologix has been named one of the winners of the Venture Kick stage II start up competition. “We are very happy to have passed this important milestone in the V

ABOLOGIX awarded a two year Innosuisse Innovation

Geneva, Switzerland, Juy 24, 2020. Abologix has been granted a 2 year Innosuisse Innovation project in collaboration with the University Hospital of Geneva (HUG). The HUG will be the research partner